Skip to main content
Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Baraliakos X, Listing J, Brandt J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Rudwaleit M, Sieper J, Braun J
Arthritis Res Ther
2005,
7
:R439-44
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 5 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
Sieper J, Rudwaleit M
Ann Rheum Dis
2005 Nov,
64 Suppl 4
:iv61-4
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
2.
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Bijlsma JW, Dougados M, Emery P, Keystone EC, Klareskog L, Mease PJ
Ann Rheum Dis
2005 Nov,
64 Suppl 4
:iv2-14
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
3.
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, ASAS Working Group
Ann Rheum Dis
2006 Mar,
65
:316-20
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
4.
ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J, 'ASsessment in AS' international working group , European League Against Rheumatism
Ann Rheum Dis
2006 Apr,
65
:442-52
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
5.
TNFalpha blockade in human diseases: an overview of efficacy and safety.
Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y, Braun J, Reed E, Gjertson D, Singh RR
Clin Immunol
2008 Jan,
126
:13-30
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
This article is also cited by
2 articles
in BioMed Central
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 5 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.